logo
Forget weight-loss jabs: These nutritionist-approved foods can naturally cut fat without side effects

Forget weight-loss jabs: These nutritionist-approved foods can naturally cut fat without side effects

iStock
Dubai-based dietitian suggests that everyday foods like avocados, oats, eggs, and chia seeds can mimic the effects of popular weight-loss injections—without the side effects. These natural options support digestion, suppress cravings, and help regulate blood sugar. (Image: iStock)
In an era where weight-loss injections are making headlines for their dramatic results, one nutrition expert argues you might not need a prescription to slim down—just a better grocery list.
Maria AbiHanna, a Dubai-based dietitian and certified eating disorder practitioner, recently told The Daily Mail that several simple food groups can naturally mimic the effects of popular weight-loss medications that stimulate the GLP-1 hormone. These jabs—originally designed for diabetes and now used widely for weight loss—work by slowing digestion and promoting satiety. But they also come with a host of unpleasant side effects, from nausea and diarrhoea to long-term dependency concerns.
AbiHanna's point? Your fridge can do what the pharmacy does—without the backlash. At the top of her list are healthy fats like avocados, nut butters, and oily fish such as mackerel. These aren't just calorie-rich snacks—they help your body absorb fat-soluble vitamins like D and E, promote heart health, and most importantly, curb cravings. While fats were once the villains of weight loss, science now champions them as satiety superstars. Protein is another powerful player. Eggs, Greek yogurt, and edamame beans pack in protein that doesn't just fuel your muscles—it also 'turns off cravings before they even start,' AbiHanna explained. A single serving of Greek yogurt offers up to 20 grams of protein, helping you stay full for hours without snacking.
Then there's fibre—the often-overlooked hero of gut health and sustained fullness. Foods like oats, lentils, and chia seeds not only slow digestion but also help keep blood sugar steady. Chia seeds, for example, expand in your stomach, literally creating a sense of fullness. Lentils and oats, with their mix of fibre and resistant starch, offer long-lasting satisfaction without a calorie spike. Despite these benefits, most people fall short. According to the British Dietetic Association, the average Brit consumes only 18g of fibre daily—well below the recommended 30g. Yet a 2023 study in Science confirmed that those on fibre-rich diets lost significantly more weight than others, even when calorie intake was roughly the same.
Leafy greens and high-volume, low-calorie veggies like cucumber and broccoli play a clever trick on the body: they stretch the stomach without loading it with calories. 'To feel fuller on fewer calories,' AbiHanna advised, 'add greens to every meal.' And when it comes to carbohydrates—often blamed for weight gain—it's the type that counts. Slow-burning carbs like sweet potatoes and quinoa release energy gradually, preventing the spikes and crashes that lead to cravings. 'Think long-term fuel, not fast-burning fire,' she said. 'If it stabilises your blood sugar, it stabilises your hunger.'
Even snack time can be strategic. Green tea and matcha can suppress hunger pangs naturally, and simple combinations like apple slices provide the ideal balance of fibre and fat to keep you satisfied without reaching for sugary alternatives. AbiHanna sums it up best: 'This isn't about dieting or willpower—it's about working with your biology, not against it.'
Weight-loss drugs have skyrocketed in popularity, some users report losing up to 20% of their body weight in mere months. But the side effects—and the dependency risks—are leading many to seek sustainable, food-based alternatives. While medications have their place in combating obesity, this fresh perspective reminds us that sometimes the simplest solutions lie not in a syringe, but in a salad bowl.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

These 3-ingredient donuts are both gluten and guilt free
These 3-ingredient donuts are both gluten and guilt free

Hindustan Times

time40 minutes ago

  • Hindustan Times

These 3-ingredient donuts are both gluten and guilt free

When the last day of the month rolls out on a Monday, the blues hit harder than usual. Guilt-free blueberry donuts for your weekday binge(Photos: Kickass Baker, Recipes Food and Cooking) Luckily we can fight the blues with some literal blueberries! Now there's nothing quite like a bowl of fresh, ice cold blueberries but every now and then, you need that indulgent sweet treat to egg you on for the week. This air fryer recipe is just that, giving you the indulgence sans any of the guilt. It's quick, crisp, gorgeous and most importantly, gluten free. And the pay off? Bougie to say the least. Refer to the recipe below. Ingredients: Almond flour - 1 cup, plain Greek yoghurt - 1 cup, baking powder - 1tsp, blueberries - 1/3 cup, melted sugar-free white chocolate chips (optional for glaze) Method: Dump the almond flour, baking powder and plain Greek yoghurt into a mixing bowl and give it a good mix. If the 'dough' feels a little too tacky, go in with some more almond flour. This is where you fold in the blueberries and immediately roll the dough into small golf-sized balls. Don't make these too big otherwise they may remain raw in the middle and overcooked on the outside. A good tip would be to first have the dough ready sans the blueberries and then work the former around the latter, lest the blueberries start bleeding and lose their juices before the dough balls make it to the air fryer. Place these in the air fryer, spritz with some cooking oil and cook at 185C for about 8 to 10 minutes or till a crisp golden-brown hue is achieved. If you're really feeling like treating yourself go in with some melted white chocolate for the glaze and you're done! (recipe from iRick Wiggins of Keto Snackz) A batch of these air fryer blueberry donuts will last you the week in your fridge and can be softened and crisped up in the air fryer in under two minutes. So will you be indulging your sweet tooth early in the week?

India's Pharma sector falters in H1 2025; index falls over 6% becoming the second worst-performing sector
India's Pharma sector falters in H1 2025; index falls over 6% becoming the second worst-performing sector

Mint

time4 hours ago

  • Mint

India's Pharma sector falters in H1 2025; index falls over 6% becoming the second worst-performing sector

India's pharmaceutical sector has come under significant pressure in 2025, with the Nifty Pharma index falling more than 6 percent during the first half of the year. In stark contrast, the broader Nifty 50 index gained nearly 8 percent over the same period. Investor sentiment has turned sharply bearish amid a series of domestic and global concerns ranging from export tariffs to macroeconomic uncertainty. The downturn has been broad-based. Natco Pharma suffered the steepest decline, plunging around 34 percent. IPCA Labs dropped over 20 percent, while Aurobindo Pharma, Lupin, Granules India, Mankind Pharma, Ajanta Pharma, and Alkem Labs lost between 12–20 percent. Even stalwarts such as Biocon, Cipla, Dr Reddy's, JB Chemicals, and Sun Pharma saw setbacks of 1–10 percent. Amid the decline, a few companies have stood out. Laurus Labs recorded a 19 percent gain, Abbott India rose 16 percent, Divi's Labs climbed 10 percent, and Glenmark Pharma increased by 8.6 percent. Torrent Pharma and Zydus Life also managed modest gains. The sector's weakening fortunes are linked to several concerns. Large-scale foreign institutional investor (FII) exits, particularly from export-sensitive industries, have weighed heavily on pharma stocks. Macro risks such as sluggish global growth, higher interest rates, and the ongoing US–China trade tensions have exacerbated the situation. Market anxiety escalated after former US President Trump's announcements—first in April and again in June—hinting at enforcing pharmaceutical tariffs of up to 25 percent. Such measures would severely impact Indian drugmakers, which export up to 40 percent of their generics and specialty medicines to the US. Nuvama Institutional Equities acknowledged investor caution surrounding large-cap pharma, particularly due to US policy threats and product-mix exposure. It noted, however, that interest remains strong in CDMOs and GLP‑1 drug manufacturers, while healthcare services appear poised for double-digit growth thanks to facility expansions. Tariff and product-mix concerns: Nuvama flagged persistent worries about a potential shift in US import policy, which could impose higher duties on Indian generics such as gRevlimid, gMyrbetriq, gSpiriva, gJynarque, and Lanreotide. The next two months are seen as pivotal for potential rule changes. It added that Cipla's strong pipeline—featuring products like gAbraxane and gSymbicort—and market-share gains in Lanreotide may calm investor fears. Sustained interest in CDMO and GLP‑1 space: Despite US export uncertainty, investors are positive about CDMOs. Firms like Aarti Pharmalabs have benefitted from production shifts from China. Jubilant Pharmova, Divi's, and Dr Reddy's continue to prosper, supported by growth in fill-finish services and GLP‑1 demand—what Nuvama described as 'near-term opportunities.' Optimism in healthcare services: Nuvama also sees promise in healthcare infrastructure. Companies like Laxmi Dental, Jupiter Lifeline, Suraksha, Aster DM, and Jeena Sikho are expanding inpatient capacity and operating efficiently. New centres and investments in diagnostics, digital tools, and hospital beds are expected to underpin robust revenue and margin growth. Nuvama's Top Picks & Emerging Themes Analyzing their coverage, Nuvama identified several names with strong potential: Aurobindo Pharma ('Buy', ₹ 1,460 TP): Valued at around 14× FY27E EPS, its Pen‑G facility restart and pipeline investments in biologics and peptides are likely to drive growth. Jubilant Pharmova ('Buy', ₹ 1,385 TP): Positioned to benefit from re‑shoring trends in US manufacturing and sustained demand for CDMO services. Lupin ('Buy', ₹ 2,570 TP): With key US launches including gSpiriva and gXarelto, its FY26 PAT growth projection of 19 percent underpins a strong outlook. Laxmi Dental ('Buy', ₹ 530 TP): Laxmi is gaining from underpenetrated oral health markets, digital dental tools, and export growth in aligners. Jupiter Lifeline ('Buy', ₹ 1,800 TP): On track to double bed capacity with greenfield expansions and ramp up revenue through capacity utilisation. Aarti Pharma: Benefiting from new CDMO projects and expanded intermediate capabilities. Eris Life: Positioned to leverage insulin and GLP‑1 demand, expected to reach PHY26 profitability inflection. OneSource Specialty: Peptide and biologics CDMO poised for early commercial launches. Shilpa Medicare: Focusing on niche and high-value products like 505b2 and ADCs. Aster DM: With bed expansions and merger synergies, set to become a top-tier hospital chain. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Don't want ventilator or CPR? India's first living will clinic helps you decide how you'll be treated if seriously ill or unconscious
Don't want ventilator or CPR? India's first living will clinic helps you decide how you'll be treated if seriously ill or unconscious

Time of India

time4 hours ago

  • Time of India

Don't want ventilator or CPR? India's first living will clinic helps you decide how you'll be treated if seriously ill or unconscious

Although India recognised the concept of a living will back in 2018 through a Supreme Court judgment, many people still don't know how to make one. To help with this, a Mumbai hospital has started a weekly clinic to guide patients and families in preparing the legal document, as reported by TOI. The living will clinic began last week at Hinduja Hospital in Mahim. It is being led by senior neurologist Dr Roop Gursahani , who has been part of the 'dying with dignity' movement for over ten years. Palliative care expert Dr Smriti Khanna, who manages the clinic, told TOI, 'The courts shared a simplified version of the living will in 2023, but many people are still unaware of it.' She added that the clinic aims to increase public awareness and help more people understand and complete this important process. A living will, also known as an advanced life directive, allows people to state in advance the kind of medical treatment they want, or don't want, if they become seriously ill or unconscious. It covers choices like whether to be put on a ventilator or to receive CPR. In early 2024, Mumbai-based gynaecologist Dr Nikhil Datar became one of the first to register his living will. He then approached the Bombay High Court, which directed the Maharashtra government to appoint custodians for such documents in every district. The state now has 413 custodians, including two in Mumbai. Live Events 'There is a government resolution on this, but many people don't know how to access it,' Dr Datar told TOI. 'We now need to make sure this information is widely available.' According to Dr Gursahani, three types of people are showing interest in living wills: healthy youngsters worried about getting stuck in a vegetative state, elderly individuals who've had a recent health scare, and patients with chronic illnesses receiving palliative care. 'The living will has made conversations around end-of-life care more normal among those receiving palliative care,' Dr Khanna said. She added that many people fear the ICU simply because they don't understand what it involves. 'Once we explain things like ventilator use or central lines, they begin to understand what they're agreeing to. It helps them make better decisions about their advanced care.' TOI also shared the story of an 80-year-old man with heart and lung issues who made his living will with the help of the clinic. He wanted to live long enough to attend his granddaughter's wedding. After discussions, he agreed to be put on a ventilator for up to five days, but he refused resuscitation for heart problems, having seen the harsh effects of CPR on another patient. The Hinduja clinic operates every Saturday by appointment. It provides counselling and helps people draft their living wills. Once the document is ready, it is notarised with two witnesses, and copies are sent to the custodian, the person's family, and their doctors. The clinic also plans to upload draft templates and step-by-step instructions online soon. Meanwhile, the Maharashtra government has until mid-August to launch a special online portal for living wills, following orders from the Bombay High Court. 'It should work like the marriage registration portal,' said Dr Datar. Inputs from TOI

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store